Basic Information 【 display / non-display

SHIBATA Hiroyuki



Graduate School of Medicine , Doctorial Course in Medicine , Oncoregulatory Medicine



Date of Birth


Postal address

Hondo 1-1-1, Akita

Research Fields, keywords

Medical Oncology, Molecular Oncology

Mail Address

E-mail address

Telephone number


FAX number


Homepage URL

Academic Background (Undergraduate Level) 【 display / non-display

  • Tohoku University   Faculty of Medicine   1987.03  Graduated

Academic Background (Graduate Level) 【 display / non-display

  • Tohoku University  Graduate School,Division of Medicine  Doctor's Degree Program  1991.03  Completed

Professional Career On-Campus 【 display / non-display

  • 2009.04

    Akita University   Graduate School of Medicine   Doctorial Course in Medicine   Oncoregulatory Medicine   Department of Clinical Oncology   Professor

Research Field(Grants-in-Aid-for-Scientific-Research classification ) 【 display / non-display

  • General internal medicine (including psychosomatic medicine)


Thesis 【 display / non-display

  • Increase in the level of P-glycoprotein mRNA expression in multidrug-resistant K562 cell lines treated with sodium butyrate is not accompanied with erythroid differentiation


    Shibata H, Kanamaru R, Sato T, Ishioka C, Konishi Y, Ishikawa A, Wakui A, Tsuruo T 

    Jpn J Cancer Res.     1991.03   The Multiple Authorship

Articles 【 display / non-display

  • Cohort study of consistency between the compliance with guidelines for chemotherapy-induced nausea and vomiting and patient outcome.

    Inoue M, Shoji M, Shindo N, Otsuka K, Miura M, Shibata H.

    BMC Pharmacology & Toxicology   2015.03

  • Inhibition of β-catenin and STAT3 with a curcumin analog suppresses gastric carcinogenesis in vivo.

    Uehara Y, Inoue M, Fukuda K, Yamakoshi H, Hoshi Y, Kanda H, Oshima M, Iwabuchi Y, Shibata H.

    Gastric Cancer   2014.10

  • Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer.

    Imai H, Soeda H, Komine K, Otsuka K, Shibata H.

    BMC Palliative Care   2013.10

  • Utility of Measuring Circulating Tumor Cell Counts to Assess the Efficacy of Treatment for Carcinomas of Unknown Primary Origin.

    Komine K, Inoue M, Otsuka K, Fukuda K, Nanjo H, Shibata H.


  • A Phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients.

    Kanai M, Otsuka K, SatoM, Nishimura T, Mori Y, Kawaguchi M, Hatano E, Kodama Y, Matsumoto S, Murakami Y, Imaizumi A, Chiba T, Nishihira J, Shibata H.

    Cancer Chemotherapy and Pharmacology   71 ( 6 )   1521 - 1530   2013.03

display all >>